1. AA genotype of deSNP rs6726639 of MERTK gene is associated with development of Hepatocellular Carcinoma after eradication of Hepatitis C Virus infection. (February 2019) Authors: Di Marco, L.; Calvaruso, V.; Grimaudo, S.; Petta, S.; Pipitone, M.R.; Cabibbo, G.; Conte, E.; Magro, B.; Rini, F.; Celsa, C.; Cammà, C.; Craxì, A.; Di Marco, V. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.53 THE LEGACY OF COVID-19 PANDEMICS: REMOTE MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AS AN EFFECTIVE MANAGEMENT STRATEGY. (September 2021) Authors: Busacca, A.; Sinagra, E.; Guida, L.; Carrozza, L.; Maida, M.; Battaglia, S.; Celsa, C.; Cammà, C.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. (February 2019) Authors: Cabibbo, G.; Celsa, C.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Rossi, M.; Magro, B.; Rini, F.; Distefano, M.; Larocca, L.; Prestileo, T.; Malizia, G.; Bertino, G.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Di Rosolini, M.A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?. (March 2021) Authors: Celsa, C.; Cabibbo, G.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Stornello, C.; Giuffrida, P.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lack of substantial improvements in the landscape of alcohol-related hepatocellular carcinoma in the last 15 years: The need to improve cancer prevention and surveillance. (March 2023) Authors: Reggidori, N.; Bucci, L.; Santi, V.; Stefanini, B.; Lani, L.; Rampoldi, D.; Caturelli, E.; Farinati, F.; Masotto, A.; Stefanini, B.; Mega, A.; Biasini, E.; Foschi, F.G.; Svegliati-Baroni, G.; Sangiovanni, A.; Campani, C.; Raimondo, G.; Vidili, G.; Gasbarrini, A.; Celsa, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?. (March 2023) Authors: Celsa, C.; Cabibbo, G.; Rizzo, G.E.M.; Giuffrida, P.; Enea, M.; Di Maria, G.; Antonucci, M.; Giacchetto, C.M.; Rancatore, G.; Grassini, M.V.; Ciccia, R.; Grova, A.; Salvato, M.; Battaglia, S.; Vaccaro, M.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.02.3 SEQUENTIAL THERAPY IN THE MANAGEMENT OF MODERATE-TOSEVERE ULCERATIVE COLITIS: MARKOVIAN MODELS TO GUIDE TREATMENT CHOICES. (May 2022) Authors: Busacca, A.; Sinagra, E.; Battaglia, S.; Celsa, C.; Carrozza, L.; Muscarella, S.; Crispino, F.; Brinch, D.; Guida, L.; Camma, C.; Cappello, M. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.04.3 FIRST-LINE IMMUNE CHECKPOINT INHIBITOR-BASED SEQUENTIAL THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A RATIONALE FOR FUTURE TRIALS. (September 2021) Authors: Cabibbo, G.; Celsa, C.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Petta, S.; Calvaruso, V.; Di Marco, V.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.07.1 DIRECT ACTING ANTIVIRALS AFTER SUCCESSFUL TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA IMPROVE SURVIVAL AND REDUCE HEPATIC DECOMPENSATION IN HCV-CIRRHOTIC PATIENTS. (25th March 2019) Authors: Celsa, C.; Cabibbo, G.; Calvaruso, V.; Petta, S.; Cacciola, I.; Cannavò, M.R.; Madonia, S.; Rossi, M.; Magro, B.; Rini, F.; Distefano, M.; Larocca, L.; Prestileo, T.; Malizia, G.; Bertino, G.; Benanti, F.; Licata, A.; Scalisi, I.; Mazzola, G.; Di Rosolini, M.A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.08.2 NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: WHO IS THE WINNER?. (March 2023) Authors: Celsa, C.; Cabibbo, G.; Rizzo, G.E.M.; Giuffrida, P.; Di Maria, G.; Battaglia, S.; Vaccaro, M.; Enea, M.; Giacchetto, C.; Rancatore, G.; Grassini, M.; Ciccia, R.; Grova, A.; Salvato, M.; Camma, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗